References in periodicals archive ?
Its first ANDA, Terbinafine HCl Tablets, was launched in July 2007, and in order to offer patients and customers a broad dermatological product portfolio, Harris has been acquiring and licensing additional products in its niche.
Food and Drug Administration for Terbinafine HCl tablets, equivalent to 250 milligram base with a Paragraph IV certification on the 4,755,534 patent.
Tenders are invited for Terbinafine Hcl 1 Percent Cream For Topical Use